November 12, 2007 – At RSNA 2007, Advanced Research Technologies will showcase the SoftScan optical imaging device, designed for the detection, diagnosis and characterization of breast cancer.

The device provides functional or physiological information about a lesion, such as tissue perfusion and blood oxygen content, which the company says allows characterization of a lesion as benign or malignant.

Use of the device does not involve painful compression of the breast or ionizing radiation. It can image women with dense breast tissue or who have undergone hormonal therapy, and reportedly reduces the need for painful biopsies.

The SoftScan system includes a patient table, scanning accessories, an optical acquisition unit, and a processing and display workstation installed on a separate mobile unit. The system can be installed in any clinical setting similar in size to a stereotactic biopsy suite.

For more information: www.art.ca


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Lung Imaging

Oct. 20, 2026 — Optellum has announced that its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI is ...

Time October 21, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Prostate Cancer

Aug. 13, 2026 — Artera has announced the enrollment of the first patient in its DIRECT-AI registry study, marking the ...

Time August 14, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Subscribe Now